Fatemeh Molaabasi | Health Technology | Best Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Fatemeh Molaabasi | Health Technology | Best Researcher Award 

Assistant Professor | Breast Cancer Research Center, Motamed Cancer Institute, ACECR | Iran

Dr. Fatemeh Molaabasi is an accomplished scholar in analytical chemistry, biomaterials, and medical nanotechnology, serving as an Assistant Professor at the Motamed Cancer Institute, ACECR, where she contributes to the Biomaterials and Tissue Engineering and Medical Nanotechnology Research Groups. Her research advances bio-inspired nanomaterials for drug delivery, biosensing, regenerative medicine, cancer diagnostics, and theranostics, with a strong emphasis on clinically translatable platforms. She has produced a substantial body of peer-reviewed work in international journals and scholarly books and holds a record of impactful scientific contributions evidenced by a high citation profile and sustained editorial and reviewing responsibilities in leading journals. Dr. Molaabasi has pioneered innovative tools including tumor apoptosis assay platforms, viral detection systems, electrochemical biosensing strips, three-dimensional tumor models, and targeted diagnostic devices for circulating tumor cells, demonstrating excellence in merging chemistry, biology, engineering, and clinical needs. Her portfolio also includes the development of medical diagnostic kits, rapid assays, and dialysis-based devices designed to support metastatic cancer patients, reflecting a strong translational orientation toward patient-centered technology development. She has secured national funding, engaged in interdisciplinary and global research collaborations with leading academic and biomedical centers, and contributed to national innovation initiatives and industry-linked diagnostic technology development. Beyond research and innovation, she has actively served in editorial boards and scientific committees, reviewed national scientific grants, and mentored emerging researchers. Dr. Molaabasi’s work embodies a commitment to strengthening early cancer detection, precision medicine, and bio-nanotechnology infrastructure, while advancing sustainable and biocompatible nanoplatforms. Her efforts contribute to global research in cancer diagnostics and biosensors and to the development of affordable, high-performance biomedical technologies, reinforcing her role as a leader in next-generation healthcare innovation and applied nanoscience. She has 1274 citations from 55 documents with an h-index of 22.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Fathi Ganje Lou, E., Rezayan, A. H., Malekmohamadi, M., Abbasi, V., et al. (2025). Very simple and ultra-sensitive fluorescence resonance energy transfer aptasensor for turn-on C-reactive protein detection in biological matrices.

2. Feizi, F., Molaabasi, F., Ezati, M., Shamsipur, M., Mousavi, F., Roshanfekr, A., et al. (2025). Ratiometric fluorescence chiral sensors for pH monitoring and its applications in indicator paper and bioimaging. Analytical Chemistry.

3. Molaabasi, F., Mohseni, N., Hajipour-Verdom, B., Agheli, A., et al. (2025). Ultra-efficient label-free cell death detection based on multifunctional colorimetric fluorescent in-situ silver nanocluster/graphene nanohybridzyme and its application in environmental biological samples and cellular imaging. Biosensors and Bioelectronics.

4. Shahrashoob, M., Dehshiri, M., Yousefi, V., Moassesfar, M., Saberi, H., et al. (2025). Optical and electrochemical biosensors for detection of pathogens using metal nanoclusters: A systematic review. Biosensors.

5. Besharati, M., Radi, H. C., & Molaabasi, F. (2025). A highly sensitive and simple platform for enzyme-free detection of ethanol based on a nano-porous glassy carbon electrode with electrodeposited Ni nanoparticles. Russian Journal of Electrochemistry.

Yang Zhang | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Yang Zhang | Clinical Medicine | Best Researcher Award 

Director | Department of Laboratory Medicine Chongqing University | China

Dr. Yang Zhang, Ph.D., currently serves as Director of the Department of Laboratory Medicine at Chongqing University Affiliated Renji Hospital and is an Associate Chief Physician, Postdoctoral Fellow in Clinical Laboratory Diagnostics, and doctoral and master’s supervisor at Chongqing University. She earned her Bachelor of Medicine in Laboratory Medicine (2008), Master of Medicine in Clinical Laboratory Diagnostics (2011), and Ph.D. in Clinical Laboratory Diagnostics (2015) from the Third Military Medical University, complemented by a Ministry of Education-sponsored visiting scholarship at Loma Linda University, USA (2012–2015). Her research centers on precision molecular diagnostics in oncology, with a special focus on POCT rapid diagnostic reagents and spectroscopy-based label-free diagnostic techniques. Dr. Zhang has led multiple high-level research projects, including three funded by the National Natural Science Foundation of China, one by the National Key R&D Program, and numerous provincial and military projects, securing over 6.88 million RMB in funding. She has published more than 40 academic papers as first or corresponding author, with 15 SCI-indexed articles, an H-index of 24, and a single paper cited over 280 times. Her scholarly contributions extend to 12 Chinese invention patents, 1 international PCT patent, and five co-edited scientific monographs, including works on molecular diagnostics and terahertz applications. Dr. Zhang’s achievements have been recognized with numerous honors, such as Chongqing High-Level Young Medical Talent (2022), the “Top Ten Young Scientists in Shapingba District” (2022), First Prize in the Chongqing Association for Science and Technology Innovation (2023), and the National Laboratory Medicine Science and Technology Innovation Award (2021). She also serves as a reviewer for the NSFC and contributes to several national professional committees in laboratory medicine. She has 1044 citations from 43 documents with an h-index of 16.

Profile: Scopus | ORCID 

Publications

1. Zhang, Y. (2020). ENT1 inhibition attenuates apoptosis by activation of cAMP/pCREB/Bcl2 pathway after MCAO in rats. Experimental Neurology, 331, 113362.

2. Zhang, Y. (2020). Identification of immune-related prognostic biomarkers based on the tumor microenvironment in 20 malignant tumor types with poor prognosis. Frontiers in Oncology, 10, 1008.

3. Tian, H., Yuan, C., Liu, Y., Xia, K., Li, M., Xie, F., Chen, Q., Chen, M., Fu, W., & Zhang, Y. (2020, July 28). A sample-to-answer quantification platform for point-of-care testing of circulating microRNAs based on allosteric spherical nanoprobe. Preprint.

4. Zhang, Y. (2020). Evaluation of the reliability of six commercial SERS substrates. Plasmonics, 15(5), 1323–1332.

5. Zhang, Y. (2020). Dataset concerning plasmonic thermal destruction of murine melanoma by gold nanoparticles obtained by green chemistry. Data in Brief, 30, 105370.